Pharmaceuticals

Asthma Drugs Market Expected to Reach $33.62 Billion by 2030 with 6.3% CAGR

April 6, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Expected Market Size Of The Asthma Drugs Market From 2026 To 2030?

The asthma drugs market size has experienced significant expansion in recent years. Its value is projected to rise from $24.93 billion in 2025 to $26.3 billion in 2026, growing at a compound annual growth rate (CAGR) of 5.5%. The notable increase in the market during the historic period can be linked to the rising prevalence of asthma, limited access to advanced therapies, a high incidence of respiratory infections, the continued usage of traditional inhalers, and awareness campaigns by health organizations.

The asthma drugs market size is expected to experience substantial growth in the upcoming years. It is forecast to grow to $33.62 billion by 2030, achieving a compound annual growth rate (CAGR) of 6.3%. The expansion observed during the forecast period can be attributed to the proliferation of biologics & monoclonal antibodies, the adoption of smart inhalers, increased digital health integration, the broadening of preventive care programs, and a rise in pediatric asthma diagnosis. Key trends for this period include personalized asthma treatment, the development of telemedicine & remote patient monitoring, the advancement of biologic and targeted therapies, innovation in inhalation devices, and an elevated focus on pediatric asthma care.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11924&type=smp

Which Growth Drivers Are Contributing To The Progress Of The Asthma Drugs Market?

An increase in respiratory illnesses is expected to fuel growth in the asthma medication market. These conditions are health issues impacting the respiratory system, encompassing vital organs such as the lungs, bronchi, trachea, larynx, pharynx, and nasal passages. The widespread occurrence of respiratory diseases necessitates the application of asthma pharmaceuticals to control and ease the manifestations linked with such ailments. With the broader spread of respiratory disorders, especially asthma which is marked by persistent inflammation and narrowed airways, the need for potent treatments grows. For example, a research investigation released in December 2023 by JAMA Network Open, a medical publication of the American Medical Association, estimated that the global incidence of chronic obstructive pulmonary disease (COPD) could approach almost 600 million cases globally by 2050, representing a 23% rise in its occurrence. Consequently, the increasing incidence of respiratory ailments will propel the asthma drug market’s expansion.

Which Segments Are Included In The Analysis Of The Asthma Drugs Market?

The asthma drugs market covered in this report is segmented –

1) By Type Of Asthma: Allergic, Non-Allergic

2) By Asthma Trigger Type: Adult-Onset Asthma, Child-Onset Asthma, Cough-Induced Asthma, Exercise-Induced Asthma, Occupational Asthma, Nocturnal Asthma, Steroid-Resistant Asthma

3) By Therapy: Preventive

4) By Drug Class: Bronchodilators, Monoclonal Antibodies, Anti-Inflammatory Drugs, Combination Drugs

5) By End-User: Asthma Patients

Subsegments:

1) By Allergic: Inhaled Corticosteroids (ICS), Leukotriene Receptor Antagonists (LTRAs), Monoclonal Antibodies

2) By Non-Allergic: Short-Acting Beta Agonists (SABAs), Long-Acting Beta Agonists (LABAs), Oral Corticosteroids

Which Trends Are Impacting The Growth Of The Asthma Drugs Market?

Leading companies in the asthma drug market are concentrating on developing novel products, such as fixed-dose triple-drug combinations, to enhance lung function, improve symptom management, and decrease exacerbations in patients experiencing uncontrolled asthma. These fixed-dose triple-drug combinations integrate several therapeutic agents into a single inhalation treatment to boost patient adherence and overall effectiveness. As an illustration, in January 2023, Lupin Ltd., an India-based pharmaceutical firm, introduced DIFIZMA, a fixed-dose combination of indacaterol, glycopyrronium, and mometasone, intended for managing inadequately controlled asthma in adults and adolescents aged twelve years and above. Approved by the Drug Controller General of India (DCGI), DIFIZMA broadened Lupin’s respiratory product range as the sole fixed-dose triple-drug combination available for asthma patients requiring improved symptom control. Lupin specializes in the development and manufacturing of a broad spectrum of pharmaceutical products, including inhalation therapies for respiratory conditions.

Which Key Industry Participants Are Active In The Asthma Drugs Market?

Major companies operating in the asthma drugs market are Pfizer Inc., Roche Holding AG, Merck & Co. Inc., Sanofi S.A., AstraZeneca PLC., GlaxoSmithKline PLC., Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Novartis International AG, Mylan N.V., Cipla Limited, Chiesi Farmaceutici S.p.A., Sun Pharmaceutical Industries Limited, Hikma Pharmaceuticals, Mundipharma International Limited, Lupin Limited, Glenmark Pharmaceuticals Limited, Hetero Drugs Limited, Alembic Pharmaceuticals Limited, Sunovion Pharmaceuticals Inc., Amphastar Pharmaceuticals Inc., Beximco Pharmaceuticals Ltd., Innoviva Inc., Vectura Group, Circassia Group PLC, Pulmatrix Inc.

Read the full asthma drugs market report here:

https://www.thebusinessresearchcompany.com/report/asthma-drugs-global-market-report

What Are The Leading Geographic Regions In The Asthma Drugs Market?

North America was the largest region in the asthma drugs market in 2025. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the asthma drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Asthma Drugs Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=11924&type=smp

Browse Through More Reports Similar to the Global Asthma Drugs Market 2026, By The Business Research Company

Asthma Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/asthma-drugs-global-market-report

Anti Asthmatics And Copd Drugs Market 2026

https://www.thebusinessresearchcompany.com/report/anti-asthmatics-and-copd-drugs-market

Anti Asthmatics And Copd Drugs Market 2026

https://www.thebusinessresearchcompany.com/report/anti-asthmatics-and-copd-drugs-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795